ERBB2 and neoplasm: HER2 induces MAPK signaling pathways (RAS-RAF-MEK-ERK) and phosphatidylinositol 3-kinase (PI3K) pathways (PI3K-AKT-mTOR) that result in cell proliferation, angiogenesis and controlled tumor growth [48].